Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III …

E Versteijne, M Suker, K Groothuis… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for
resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven …
被引用次数：852 相关文章

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

E Versteijne, M Suker, K Groothuis… - Journal of Clinical …, 2020 - cris.maastrichtuniversity.nl
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline
Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial …

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

E Versteijne, M Suker, K Groothuis… - Journal of Clinical …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> PURPOSE</jats: title>< jats: p> Preoperative chemoradiotherapy
may improve the radical resection rate for resectable or borderline resectable pancreatic …

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

E Versteijne, M Suker, K Groothuis… - Journal of Clinical …, 2020 - europepmc.org
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline
Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial …

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

Dutch Pancreatic Cancer Group - Journal of …, 2020 - researchinformation.amsterdamumc …
PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for
resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven …

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

E Versteijne, M Suker, K Groothuis… - Journal of Clinical …, 2020 - repub.eur.nl
PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for
resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven …

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

E Versteijne, M Suker, K Groothuis… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Preoperative chemoradiotherapy may improve the radical resection rate for
resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven …

Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III …

E Versteijne, M Suker… - Journal of …, 2020 - scholarlypublications …
PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for
resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven …

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase …

E Versteijne, M Suker, K Groothuis… - Journal of Clinical …, 2020 - europepmc.org
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline
Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial …